Asthma Allergy Immunology

Asthma Allergy Immunology

2020, Vol 18, Num, 4     (Pages: 001-007)

Asthma as a Comorbid Disease in COVID-19

Ayşe BAÇÇIOĞLU 1, Sevim BAVBEK 2,

1 Department of Chest Diseases, Division of Allergy and Clinical Immunology, Kirikkale University, School of Medicine, Kirikkale, Turkey
2 Department of Chest Diseases, Division of Allergy and Clinical Immunology, Ankara University, School of Medicine, Ankara, Turkey

DOI: 10.21911/aai.565
Viewed: 129
 - 
Downloaded : 47

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that causes coronavirus disease 2019 (COVID-19). In terms of asthma and COVID-19, there is also a risk of experiencing an asthma exacerbation triggered by coronavirus infection beyond the direct risk of the infection itself. As a comorbid disease, the prevalence of COVID-19 infection in asthma patients is not clear. In addition, the influence of asthma on the severity of COVID-19 has not been reported. The aim of this review was to summarize the reported worldwide data about the prevalence and the clinical characteristics of patients with asthma during COVID-19 infection.

Keywords : Asthma, severe asthma, asthma attack, viral infection, coronavirus disease 2019, COVID-19, SARS-CoV-2